Skip to main content
Top
Published in: Journal of Gastroenterology 11/2019

01-11-2019 | Constipation | Original Article—Alimentary Tract

Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation

Authors: Ka Ming Yeh, Olle Johansson, Huy Le, Karan Rao, Irit Markus, Dayashan Shevy Perera, David Zachary Lubowski, Denis Warwick King, Li Zhang, Hongzhuan Chen, Lu Liu

Published in: Journal of Gastroenterology | Issue 11/2019

Login to get access

Abstract

Background

Cystic fibrosis transmembrane conductance regulator (CFTR) was recently found in the enteric nervous system, where its role is unclear. We aimed to identify which enteric neuronal structures express CFTR, whether CFTR modulates enteric neurotransmission and if altered CFTR expression is associated with slow transit constipation (STC).

Methods

Immunofluorescence double labeling was performed to localize CFTR with various neuronal and glial cell markers in the human colon. The immunoreactivity (IR) of CFTR and choline acetyltransferase (ChAT) on myenteric plexus of control and STC colon was quantitatively analyzed. In control colonic muscle strips, electrical field stimulation (EFS) evoked contractile responses and the release of acetylcholine (ACh) was measured in the presence of the CFTR channel inhibitor, CFTR(inh)-172.

Results

CFTR-IR was densely localized to myenteric ganglia, where it was co-localized with neuronal markers HuC/D and β-tubulin, and glial marker S-100 but little with glial fibrillary acidic protein. Vesicular ACh transport was almost exclusively co-localized with CFTR, but neurons expressing nitric oxide synthase were CFTR negative. Significant reductions of CFTR-IR (P < 0.01) and ChAT-IR (P < 0.05) were observed on myenteric ganglia of STC compared to control. Pre-treatment of colonic muscle strips with CFTR(inh)-172 (10 µM) significantly inhibited EFS-evoked contractile responses (P < 0.01) and ACh release (P < 0.05).

Conclusions

Co-localization of CFTR-IR with cholinergic markers, inhibition of EFS-induced colonic muscle contractility and ACh release by CFTR(inh)-172 suggest that CFTR modulates enteric cholinergic neurotransmission. The downregulation of CFTR and ChAT in myenteric ganglia of STC correlated with the impaired contractile responses to EFS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med. 2012;209:1263–72.PubMedCentralCrossRefPubMed Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med. 2012;209:1263–72.PubMedCentralCrossRefPubMed
2.
go back to reference Char JE, Wolfe MH, Cho HJ, et al. A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H–5T cystic fibrosis subjects taking ivacaftor. PLoS ONE. 2014;9:e88564.PubMedCentralCrossRefPubMed Char JE, Wolfe MH, Cho HJ, et al. A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H–5T cystic fibrosis subjects taking ivacaftor. PLoS ONE. 2014;9:e88564.PubMedCentralCrossRefPubMed
3.
go back to reference Oca F, Dreux S, Gerard B, et al. Amniotic Fluid Digestive Enzyme Analysis Is Useful for Identifying CFTR Gene Mutations of Unclear Significance. Clin Chem. 2009;55:2214–7.CrossRefPubMed Oca F, Dreux S, Gerard B, et al. Amniotic Fluid Digestive Enzyme Analysis Is Useful for Identifying CFTR Gene Mutations of Unclear Significance. Clin Chem. 2009;55:2214–7.CrossRefPubMed
4.
go back to reference Sorio C, Buffelli M, Angiari C, et al. Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. PLoS ONE. 2011;6:e22212.PubMedCentralCrossRefPubMed Sorio C, Buffelli M, Angiari C, et al. Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. PLoS ONE. 2011;6:e22212.PubMedCentralCrossRefPubMed
5.
go back to reference Johansson J, Vezzalini M, Verze G, et al. Detection of CFTR protein in human leukocytes by flow cytometry. Cytometry A. 2014;85:611–20.CrossRefPubMed Johansson J, Vezzalini M, Verze G, et al. Detection of CFTR protein in human leukocytes by flow cytometry. Cytometry A. 2014;85:611–20.CrossRefPubMed
6.
go back to reference Verloo P, Kocken CH, Van der Wel A, et al. Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients. J Biol Chem. 2004;279:10316–22.CrossRefPubMed Verloo P, Kocken CH, Van der Wel A, et al. Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients. J Biol Chem. 2004;279:10316–22.CrossRefPubMed
7.
go back to reference Su M, Guo Y, Zhao Y, et al. Expression of cystic fibrosis transmembrane conductance regulator in paracervical ganglia this paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the journal's usual peer review process. Biochem Cell Biol. 2010;88:747–55.CrossRefPubMed Su M, Guo Y, Zhao Y, et al. Expression of cystic fibrosis transmembrane conductance regulator in paracervical ganglia this paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the journal's usual peer review process. Biochem Cell Biol. 2010;88:747–55.CrossRefPubMed
8.
go back to reference Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73.CrossRefPubMed Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73.CrossRefPubMed
9.
go back to reference Dalli J, Rosignoli G, Hayhoe RP, et al. CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway. Am J Pathol. 2010;177:176–86.PubMedCentralCrossRefPubMed Dalli J, Rosignoli G, Hayhoe RP, et al. CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway. Am J Pathol. 2010;177:176–86.PubMedCentralCrossRefPubMed
10.
go back to reference Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. Gut. 2001;48:70–4.PubMedCentralCrossRefPubMed Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. Gut. 2001;48:70–4.PubMedCentralCrossRefPubMed
11.
go back to reference McLatchie LM, Young JS, Fry CH. Regulation of ACH release from guinea pig bladder urothelial cells: potential role in bladder filling sensations. Br J Pharmacol. 2014;171:3394–403.PubMedCentralCrossRefPubMed McLatchie LM, Young JS, Fry CH. Regulation of ACH release from guinea pig bladder urothelial cells: potential role in bladder filling sensations. Br J Pharmacol. 2014;171:3394–403.PubMedCentralCrossRefPubMed
12.
go back to reference Ochodnicky P, Michel MB, Butter JJ, et al. Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium. Pharmacol Res. 2013;70:147–54.CrossRefPubMed Ochodnicky P, Michel MB, Butter JJ, et al. Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium. Pharmacol Res. 2013;70:147–54.CrossRefPubMed
13.
go back to reference Lubowski DZ, Chen FC, Kennedy ML, et al. Results of colectomy for severe slow transit constipation. Dis Colon Rectum. 1996;39:23–9.CrossRefPubMed Lubowski DZ, Chen FC, Kennedy ML, et al. Results of colectomy for severe slow transit constipation. Dis Colon Rectum. 1996;39:23–9.CrossRefPubMed
14.
go back to reference Wong SW, Lubowski DZ. Slow-transit constipation: evaluation and treatment. ANZ J Surg. 2007;77:320–8.CrossRefPubMed Wong SW, Lubowski DZ. Slow-transit constipation: evaluation and treatment. ANZ J Surg. 2007;77:320–8.CrossRefPubMed
16.
go back to reference Bassotti G, Villanacci V, Maurer CA, et al. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41–6.PubMedCentralCrossRefPubMed Bassotti G, Villanacci V, Maurer CA, et al. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41–6.PubMedCentralCrossRefPubMed
17.
go back to reference Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation. Hepatogastroenterology. 2002;49:1540–4.PubMed Tomita R, Tanjoh K, Fujisaki S, et al. Regulation of the enteric nervous system in the colon of patients with slow transit constipation. Hepatogastroenterology. 2002;49:1540–4.PubMed
18.
go back to reference Liu L, Shang F, Morgan MJ, et al. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther. 2009;329:282–9.CrossRefPubMed Liu L, Shang F, Morgan MJ, et al. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther. 2009;329:282–9.CrossRefPubMed
19.
20.
go back to reference Björnsson ES, Chey WD, Hooper F, et al. Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT3 pathways. Am J Physiol Gastrointest Liver Physiol. 2002;283:G400–G407407.CrossRefPubMed Björnsson ES, Chey WD, Hooper F, et al. Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT3 pathways. Am J Physiol Gastrointest Liver Physiol. 2002;283:G400–G407407.CrossRefPubMed
22.
go back to reference Wong SW, Lubowski DZJ. Slow‐transit constipation: evaluation and treatment. ANZ J Surg. 2007;77:320–8.CrossRefPubMed Wong SW, Lubowski DZJ. Slow‐transit constipation: evaluation and treatment. ANZ J Surg. 2007;77:320–8.CrossRefPubMed
23.
go back to reference Strong TV, Boehm K, Collins FS. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest. 1994;93:347–54.PubMedCentralCrossRefPubMed Strong TV, Boehm K, Collins FS. Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest. 1994;93:347–54.PubMedCentralCrossRefPubMed
25.
go back to reference Cil O, Phuan PW, Lee S, et al. CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. Cell Mol Gastroenterol Hepatol. 2016;2:317–27.PubMedCentralCrossRefPubMed Cil O, Phuan PW, Lee S, et al. CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. Cell Mol Gastroenterol Hepatol. 2016;2:317–27.PubMedCentralCrossRefPubMed
26.
go back to reference Sharma S, Sharma T, Dhingra R, et al. Linaclotide-a novel secretagogue in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation. Mini Rev Med Chem. 2013;13:1685–90.CrossRefPubMed Sharma S, Sharma T, Dhingra R, et al. Linaclotide-a novel secretagogue in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation. Mini Rev Med Chem. 2013;13:1685–90.CrossRefPubMed
27.
go back to reference Xue R, Gu H, Qiu Y, et al. Expression of cystic fibrosis transmembrane conductance regulator in ganglia of human gastrointestinal tract. Sci Rep. 2016;6:30926.PubMedCentralCrossRefPubMed Xue R, Gu H, Qiu Y, et al. Expression of cystic fibrosis transmembrane conductance regulator in ganglia of human gastrointestinal tract. Sci Rep. 2016;6:30926.PubMedCentralCrossRefPubMed
28.
go back to reference Varghese F, Bukhari AB, Malhotra R, et al. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801.PubMedCentralCrossRefPubMed Varghese F, Bukhari AB, Malhotra R, et al. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801.PubMedCentralCrossRefPubMed
29.
go back to reference Dhooghe B, Noel S, Bouzin C, et al. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice. PLoS ONE. 2013;8:e77314.PubMedCentralCrossRefPubMed Dhooghe B, Noel S, Bouzin C, et al. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice. PLoS ONE. 2013;8:e77314.PubMedCentralCrossRefPubMed
30.
go back to reference Doucet L, Mendes F, Montier T, et al. Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem. 2003;51:1191–9.CrossRefPubMed Doucet L, Mendes F, Montier T, et al. Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem. 2003;51:1191–9.CrossRefPubMed
31.
go back to reference Valdivieso AG, Marin MC, Clauzure M, et al. Measurement of cystic fibrosis transmembrane conductance regulator activity using fluorescence spectrophotometry. Anal Biochem. 2011;418:231–7.CrossRefPubMed Valdivieso AG, Marin MC, Clauzure M, et al. Measurement of cystic fibrosis transmembrane conductance regulator activity using fluorescence spectrophotometry. Anal Biochem. 2011;418:231–7.CrossRefPubMed
32.
go back to reference Walsh DE, Harvey BJ, Urbach V. CFTR regulation of intracellular calcium in normal and cystic fibrosis human airway epithelia. J Membr Biol. 2000;177:209–19.CrossRefPubMed Walsh DE, Harvey BJ, Urbach V. CFTR regulation of intracellular calcium in normal and cystic fibrosis human airway epithelia. J Membr Biol. 2000;177:209–19.CrossRefPubMed
33.
go back to reference Billet A, Luo Y, Balghi H, et al. Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem. 2013;288:21815–233.PubMedCentralCrossRefPubMed Billet A, Luo Y, Balghi H, et al. Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem. 2013;288:21815–233.PubMedCentralCrossRefPubMed
35.
go back to reference Thiagarajah JR, Song Y, Haggie PM, et al. A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways. FASEB J. 2004;18:875–7.CrossRefPubMed Thiagarajah JR, Song Y, Haggie PM, et al. A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways. FASEB J. 2004;18:875–7.CrossRefPubMed
36.
go back to reference Leveque M, Penna A, Le Trionnaire S, et al. Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis. Sci Rep-Uk. 2018;8:4310.CrossRef Leveque M, Penna A, Le Trionnaire S, et al. Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis. Sci Rep-Uk. 2018;8:4310.CrossRef
37.
go back to reference Zhao YM, Migita K, Sun J, et al. MRP transporters as membrane machinery in the bradykinin-inducible export of ATP. N-S Arch Pharmacol. 2010;381:315–20.CrossRef Zhao YM, Migita K, Sun J, et al. MRP transporters as membrane machinery in the bradykinin-inducible export of ATP. N-S Arch Pharmacol. 2010;381:315–20.CrossRef
38.
go back to reference Braunstein GM, Roman RM, Clancy JP, et al. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem. 2001;276:6621–30.CrossRefPubMed Braunstein GM, Roman RM, Clancy JP, et al. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem. 2001;276:6621–30.CrossRefPubMed
39.
go back to reference Wedel T, Roblick UJ, Ott V, et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum. 2002;45:54–62.CrossRefPubMed Wedel T, Roblick UJ, Ott V, et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum. 2002;45:54–62.CrossRefPubMed
40.
go back to reference Park HJ, Kamm MA, Abbasi AM, et al. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum. 1995;38:509–13.CrossRefPubMed Park HJ, Kamm MA, Abbasi AM, et al. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum. 1995;38:509–13.CrossRefPubMed
41.
go back to reference Broadhead MJ, Bayguinov PO, Okamoto T, et al. Ca2+ transients in myenteric glial cells during the colonic migrating motor complex in the isolated murine large intestine. J Physiol. 2012;590:335–50.CrossRefPubMed Broadhead MJ, Bayguinov PO, Okamoto T, et al. Ca2+ transients in myenteric glial cells during the colonic migrating motor complex in the isolated murine large intestine. J Physiol. 2012;590:335–50.CrossRefPubMed
42.
go back to reference Boesmans W, Lasrado R, Vanden Berghe P, et al. Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. GLIA. 2015;63:229–41.CrossRefPubMed Boesmans W, Lasrado R, Vanden Berghe P, et al. Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. GLIA. 2015;63:229–41.CrossRefPubMed
43.
go back to reference MacEachern SJ, Patel BA, McKay DM, et al. Nitric oxide regulation of colonic epithelial ion transport: a novel role for enteric glia in the myenteric plexus. J Physiol. 2011;589:3333–48.PubMedCentralCrossRefPubMed MacEachern SJ, Patel BA, McKay DM, et al. Nitric oxide regulation of colonic epithelial ion transport: a novel role for enteric glia in the myenteric plexus. J Physiol. 2011;589:3333–48.PubMedCentralCrossRefPubMed
44.
go back to reference De Giorgio R, Giancola F, Boschetti E, et al. Enteric glia and neuroprotection: basic and clinical aspects. Am J Physiol Gastrointest Liver Physiol. 2012;303:G887–G89393.CrossRefPubMed De Giorgio R, Giancola F, Boschetti E, et al. Enteric glia and neuroprotection: basic and clinical aspects. Am J Physiol Gastrointest Liver Physiol. 2012;303:G887–G89393.CrossRefPubMed
45.
go back to reference Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625–32.CrossRefPubMed Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625–32.CrossRefPubMed
46.
go back to reference Neunlist M, Van Landeghem L, Mahé MM, et al. The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:90–100.CrossRefPubMed Neunlist M, Van Landeghem L, Mahé MM, et al. The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:90–100.CrossRefPubMed
47.
go back to reference Bassotti G, Chiarioni G, Imbimbo BP, et al. Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci. 1993;38:1040–5.CrossRefPubMed Bassotti G, Chiarioni G, Imbimbo BP, et al. Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci. 1993;38:1040–5.CrossRefPubMed
48.
go back to reference Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–67.CrossRefPubMed Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459–67.CrossRefPubMed
49.
go back to reference De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;293:G104–G111111.CrossRefPubMed De Lisle RC. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;293:G104–G111111.CrossRefPubMed
50.
go back to reference Lynch SV, Goldfarb KC, Wild YK, et al. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut Microbes. 2013;4:41–7.PubMedCentralCrossRefPubMed Lynch SV, Goldfarb KC, Wild YK, et al. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut Microbes. 2013;4:41–7.PubMedCentralCrossRefPubMed
51.
go back to reference De Lisle RC, Meldi L, Flynn M, et al. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr. 2008;47:406–16.CrossRefPubMed De Lisle RC, Meldi L, Flynn M, et al. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr. 2008;47:406–16.CrossRefPubMed
52.
go back to reference De Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil. 2010;22:341–e87.CrossRefPubMed De Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil. 2010;22:341–e87.CrossRefPubMed
54.
go back to reference Cil O, Phuan PW, Son JH, et al. Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation. Transl Res. 2017;182(14–26):e4. Cil O, Phuan PW, Son JH, et al. Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation. Transl Res. 2017;182(14–26):e4.
Metadata
Title
Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation
Authors
Ka Ming Yeh
Olle Johansson
Huy Le
Karan Rao
Irit Markus
Dayashan Shevy Perera
David Zachary Lubowski
Denis Warwick King
Li Zhang
Hongzhuan Chen
Lu Liu
Publication date
01-11-2019
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 11/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01610-9

Other articles of this Issue 11/2019

Journal of Gastroenterology 11/2019 Go to the issue